Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walker S Lahr

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Scientific Reports|August 16, 2018
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted NucleaseMatthew J Johnson, Kanut Laoharawee, Walker S Lahr, et al.
Cytotherapy|January 12, 2023
CRISPR-Cas9 base editors and their current role in human therapeuticsWalker S Lahr, Christopher J Sipe, Joseph G Skeate, et al.
Journal of Visualized Experiments : Jove|November 23, 2020
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9Kanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
The CRISPR Journal|April 26, 2019
EditR: A Method to Quantify Base Editing from Sanger SequencingMitchell G Kluesner, Derek A Nedveck, Walker S Lahr, et al.
Molecular Therapy. Methods & Clinical Development|May 20, 2024
Development and testing of a versatile genome editing application reporter (V-GEAR) systemEvan W Kleinboehl, Kanut Laoharawee, Walker S Lahr, et al.
Plos One|September 18, 2018
Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arraysMorito Kurata, Natalie K Wolf, Walker S Lahr, et al.
Molecular Therapy. Advances|May 25, 2026
Efficient, fratricide free non-viral engineering of CD70-targeted CAR NK cells for hematologic and solid tumor immunotherapyJae-Woong Chang, Joshua Krueger, Timothy D Folsom, et al.
Nature Communications|February 1, 2023
Germline T cell receptor exchange results in physiological T cell development and functionMeagan R Rollins, Jackson F Raynor, Ebony A Miller, et al.
International Journal of Molecular Sciences|September 9, 2022
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human MonocytesKanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
Nature Communications|January 12, 2022
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancersDerek P Wong, Nand K Roy, Keman Zhang, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Scientific Reports|August 16, 2018
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted NucleaseMatthew J Johnson, Kanut Laoharawee, Walker S Lahr, et al.
Cytotherapy|January 12, 2023
CRISPR-Cas9 base editors and their current role in human therapeuticsWalker S Lahr, Christopher J Sipe, Joseph G Skeate, et al.
Journal of Visualized Experiments : Jove|November 23, 2020
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9Kanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
The CRISPR Journal|April 26, 2019
EditR: A Method to Quantify Base Editing from Sanger SequencingMitchell G Kluesner, Derek A Nedveck, Walker S Lahr, et al.
Molecular Therapy. Methods & Clinical Development|May 20, 2024
Development and testing of a versatile genome editing application reporter (V-GEAR) systemEvan W Kleinboehl, Kanut Laoharawee, Walker S Lahr, et al.
Plos One|September 18, 2018
Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arraysMorito Kurata, Natalie K Wolf, Walker S Lahr, et al.
Molecular Therapy. Advances|May 25, 2026
Efficient, fratricide free non-viral engineering of CD70-targeted CAR NK cells for hematologic and solid tumor immunotherapyJae-Woong Chang, Joshua Krueger, Timothy D Folsom, et al.
Nature Communications|February 1, 2023
Germline T cell receptor exchange results in physiological T cell development and functionMeagan R Rollins, Jackson F Raynor, Ebony A Miller, et al.
International Journal of Molecular Sciences|September 9, 2022
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human MonocytesKanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
Nature Communications|January 12, 2022
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancersDerek P Wong, Nand K Roy, Keman Zhang, et al.
Pageof 3